Hiroyasu Higuchi
JapanFDA applicant, unverified
- Devices
- 1
What Hiroyasu Higuchi makes
Hiroyasu Higuchi manufactures LACRIFAST, a medical device designed for ocular surface treatment, specifically to facilitate tear film stabilization and improve dry eye symptoms.
The device is classified as Class II (U) under FDA regulations and is listed in the FDA’s 510(k) clearance registry. The manufacturer operates from the United States.
Catalogue
DeviceDevice · Authorizations Verified Status Regime Registry Class
Lacrifast Ref K120886
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Hiroyasu Higuchi have in the registry?
The registry currently lists 1 device for Hiroyasu Higuchi. Devices recorded under merged duplicate company entries are counted once.
Which registries list Hiroyasu Higuchi's devices?
Among its 1 most recently registered device, Hiroyasu Higuchi has devices listed in FDA 510(k) (1 device).
What are the newest devices from Hiroyasu Higuchi in the registry?
The most recently registered devices listed for Hiroyasu Higuchi include LACRIFAST.